, ritonavir) or discontinuation of a cytochrome P450 3A4 inducer for instance rifampin, carbamazepine, and phenytoin, may perhaps lead to an increase in codeine plasma concentrations with subsequently better metabolism by cytochrome P450 2D6, leading to higher morphine stages, which could maximize or extend adverse reactions and should result in https://akorn-promethazine-codein67888.blogspothub.com/31500193/the-greatest-guide-to-akorn-promethazine-codeine